Levocarnitine injections such as Cardispan are indicated for patients with secondary carnitine deficiency due to inborn errors of metabolism and for patients who develop a carnitine deficiency from undergoing hemodialysis for end stage renal disease, states DailyMed. This particular brand name of levocarnitine is not available for sale in the United States but is sold in Mexico and other Latin American countries, according to Drugs.com.
In the body, levocarnitine is an important molecule required in the production of mammalian energy. It carries long-chain fatty acids across the membrane of the mitochondria to help with energy production. Patients with metabolic disorders are typically given an intravenous injection of 50 milligrams per kilogram. In cases of metabolic crisis, patients are given a bolus of a loading dose and then given an equivalent dose over a 24-hour period, according to DailyMed. Patients receiving hemodialysis usually receive 10 to 20 milligrams per kilogram intravenously as an injection or infusion after each session.
Side effects of levocarnitine are transient nausea, vomiting, gastritis and body odor, explains DailyMed. Less frequent side effects include seizures in patients without pre-existing seizure activity and an increase in the incidence of seizures in those who have a history of seizures.